Joseph A. Sparano

Feb 23, 2024 | nature.com | Sunil S. Badve |Joseph A. Sparano

AbstractWe report the 20-year rate of ipsilateral breast event (IBE) for patients with ductal carcinoma in situ (DCIS) treated with lumpectomy without radiation on a non-randomized prospective clinical trial. Patients were enrolled in cohort 1: low- or intermediate-grade DCIS, size ≤ 2.5 cm (n = 561); or cohort 2: high-grade DCIS, size ≤ 1 cm (n = 104). The Kaplan–Meier method was used to estimate time-to-event distributions.

Nov 30, 2023 | onclive.com | Joseph A. Sparano

November 30, 2023Joseph A. Sparano, MD, FACP, discusses developments in breast cancer diagnosis and treatment. Joseph A. Sparano, MD, FACP, Ezra M. Greenspan, MD Professor in Clinical Cancer Therapeutics, chief, the Division of Hematology Oncology, deputy director, the Tisch Cancer Institute, Icahn School of Medicine, Mount Sinai, discusses developments in breast cancer diagnosis and treatment, which he presented during the Greenspan Lecture at the 41st Annual CFS®.